Strong Pneumococcal Vaccine Data From Vaxcyte Pose a Threat to Pfizer and Merck
At the highest dose tested, Vaxcyte’s shot elicited a stronger immune response against 18 of the 20 strains compared with ...
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...
infectiousdiseaseadvisor.com8d
Monovalent XBB.1.5 Vaccine Is Effective Against XBB, JN Lineage Hospitalizations
The monovalent XBB.1.5 COVID-19 vaccine is effective against XBB and JN lineage hospitalization; however, protection against the latter may be attenuated.
The American Journal of Managed Care4d
Inflation Reduction Act: A Battleground for Health Care Policy
1 At the same time, there are no fewer than 6 lawsuits currently pending against the IRA, filed by Merck, the US Chamber of ...